Director, See Remarks · 4D Molecular Therapeutics, Inc. · Common Stock
Side
SELL
Value
$1.20M
Shares
114.7K
Price
$10.47
Executed
Jun 22, 2026
Disclosed
Jun 23, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jun 22 executedJun 23, 2026 disclosed
FDMT · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Kirn David filed this Form 4 reporting a open-market sale of FDMT on Jun 22, 2026. It became public on Jun 23, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, See Remarks
Kirn Davidcik:0001834021
Issuer
4D Molecular Therapeutics, Inc.cik:0001650648
Revision history · 0
No field has changed since this record was first ingested.
